ImmunologybioRxivPreprint
A novel KIR3DL2-directed CAR T-cell therapy for cutaneous and systemic T-cell lymphomas
Federico Mario Aletti, Jinsheng Weng, Cao Cuong Le…·Sattva S. Neelapu
This paper develops a KIR3DL2-directed CAR T-cell therapy for T-cell lymphomas, showing preclinical efficacy and safety in xenograft models.
DOI 10.64898/2026.11.05.764385